Search

everythinglearnresearchcommunity

for

Search:↓

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

iPSCs are promising for studying and treating COVID-19.

The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Training programs are needed to improve home COVID-19 management practices.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Training programs are needed to improve home COVID-19 management in Mangalore.

Training programs are needed to improve home COVID-19 management and educate on vital sign monitoring and danger signs.

No clear link between androgenetic alopecia and COVID-19 was found.

Booster doses of Covaxin improve protection against the Omicron variant.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.

Long-COVID symptoms like fatigue, cognitive issues, and mobility problems can last 6-12 months but are less common after milder illness.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Quarantine increased hair fall, especially in young women, with no direct link to short sun exposure.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

Most people in South India lack knowledge about managing COVID-19 at home.

Severe hair loss may increase the risk of dying from COVID-19.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.